Video

Dr. Chase on the Importance of Genetic Testing for BRCA Mutations in Ovarian Cancer

Dana Chase, MD, FACOG, gynecologic oncologist, discusses the importance of utilizing genetic testing for BRCA mutations in ovarian cancer.

Dana Chase, MD, FACOG, gynecologic oncologist, Arizona Oncology, assistant professor,University of Arizona College of Medicine, discusses the importance of utilizing genetic testing for BRCA mutations in ovarian cancer

Approximately 15% of patients with ovarian cancer harbor an inherited, germline BRCA mutation, Chase says. Utilizing genetic testing to identify these patients is important because the presence of germline BRCA mutations increases the patient’s risk for other types of cancers, such as pancreatic or breast cancers, Chase explains. Moreover, because inherited BRCA mutations also put the patient’s family members at risk for ​inheritable cancers, identification of such mutations allows family members to undergo risk-reducing surgery, Chase adds.

Additionally, biomarker-specific treatments are available for patients with ovarian cancer who harbor hereditary mutations. As such, the results of genetic testing could inform treatment selection, Chase concludes.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center